Related Experiment Video
Updated: Jun 20, 2025
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
Redirecting Tumor Evolution with Nanocompiler Precision for Enhanced Therapeutic Outcomes
Wenshe Sun1, Biao Cai2, Zejun Zhao3
1Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, 250117, China.
Advanced Healthcare Materials
|July 23, 2024
Summary
This study introduces a nanocompiler that reprograms tumor cells, inhibiting glucose uptake and protein changes to reduce drug resistance and metastasis. The novel approach effectively targets cancer
Area of Science:
- Oncology
- Nanotechnology
- Biochemistry
Background:
- Tumor cells exhibit high plasticity, leading to drug resistance and metastasis.
- Targeting tumor hypermetabolism is a key challenge in cancer therapy.
Purpose of the Study:
- To introduce a nanocompiler for reprogramming tumor cell expression profiles.
- To stabilize the mutable state of tumor cells to overcome resistance and metastasis.
Main Methods:
- Utilized 2-deoxy-d-glucose-modified lipid nanoparticles to inhibit glucose uptake.
- Employed iron oxide nanoparticles to induce oxidative stress in tumor cells.
- Incorporated a deubiquitinase inhibitor to block adaptive protein profile changes.
Main Results:
- Demonstrated disruption of tumor energy production by targeting hypermetabolism.
- Observed a substantial reduction in tumor growth and metastatic potential.
- Showcased the ability to manipulate tumor protein expression and cellular fate.
Conclusions:
- The nanocompiler effectively reprograms tumor cells, enhancing therapeutic outcomes.
- This strategy offers a promising approach to combat drug resistance and metastasis.
- The nanocompiler steers cancer therapy towards more effective and durable results.
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K